BIOMAT Database Logo BIOMAT Database Logo

Successful treatment with bosentan for pulmonary hypertension and reduced peripheral circulation in juvenile systemic sclerosis. 2011

Masaki Shimizu, and Yoko Hashida, and Kazuyuki Ueno, and Tadafumi Yokoyama, and Yuko Nakayama, and Takekatsu Saito, and Kunio Ohta, and Kazuhiko Takehara, and Akihiro Yachie
Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan. shimizum@staff.kanazawa-u.ac.jp

Pulmonary arterial hypertension (PAH) when associated with systemic sclerosis (SSc) (SSc-PAH) is one of the leading causes of mortality and is found in 10-15% of adult patients with SSc. The ET receptor antagonist bosentan has been shown to be effective in the treatment of adult patients with SSc-PAH. Furthermore, it has been shown that bosentan ameliorates decreased skin perfusion and digital ulceration secondary to SSc. However, the effectiveness and safety of bosentan for treatment of juvenile SSc still remains unclear. We describe a case of juvenile SSc-PAH successfully treated with bosentan. The present case shows that bosentan ameliorated PAH and peripheral circulation as evaluated by cold stress thermography. No bosentan-related adverse events such as liver dysfunction were observed. Prospective randomized trials are required to validate the effectiveness of bosentan for patients with juvenile SSc; however, bosentan might be useful for the management of patients with juvenile SSc.

UI MeSH Term Description Entries
D006976 Hypertension, Pulmonary Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. Pulmonary Hypertension
D011669 Pulmonary Wedge Pressure The blood pressure as recorded after wedging a CATHETER in a small PULMONARY ARTERY; believed to reflect the PRESSURE in the pulmonary CAPILLARIES. Pulmonary Artery Wedge Pressure,Pulmonary Capillary Wedge Pressure,Pulmonary Venous Wedge Pressure,Wedge Pressure,Pressure, Pulmonary Wedge,Pressures, Pulmonary Wedge,Pulmonary Wedge Pressures,Wedge Pressure, Pulmonary,Wedge Pressures, Pulmonary,Pressure, Wedge,Pressures, Wedge,Wedge Pressures
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004452 Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic. Echocardiography, Contrast,Echocardiography, Cross-Sectional,Echocardiography, M-Mode,Echocardiography, Transthoracic,Echocardiography, Two-Dimensional,Transthoracic Echocardiography,2-D Echocardiography,2D Echocardiography,Contrast Echocardiography,Cross-Sectional Echocardiography,Echocardiography, 2-D,Echocardiography, 2D,M-Mode Echocardiography,Two-Dimensional Echocardiography,2 D Echocardiography,Cross Sectional Echocardiography,Echocardiography, 2 D,Echocardiography, Cross Sectional,Echocardiography, M Mode,Echocardiography, Two Dimensional,M Mode Echocardiography,Two Dimensional Echocardiography
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077300 Bosentan A sulfonamide and pyrimidine derivative that acts as a dual endothelin receptor antagonist used to manage PULMONARY HYPERTENSION and SYSTEMIC SCLEROSIS. 4-t-Butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide,Bosentan Anhydrous,Bosentan Monohydrate,Ro 47-0203,Ro-47-0203,Tracleer,Ro 47 0203,Ro 470203
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive

Related Publications

Masaki Shimizu, and Yoko Hashida, and Kazuyuki Ueno, and Tadafumi Yokoyama, and Yuko Nakayama, and Takekatsu Saito, and Kunio Ohta, and Kazuhiko Takehara, and Akihiro Yachie
Bosentan improves systemic sclerosis-related peripheral circulation insufficiency.
March 2011, International journal of cardiology,
Masaki Shimizu, and Yoko Hashida, and Kazuyuki Ueno, and Tadafumi Yokoyama, and Yuko Nakayama, and Takekatsu Saito, and Kunio Ohta, and Kazuhiko Takehara, and Akihiro Yachie
Successful treatment of systemic sclerosis digital ulcers and pulmonary arterial hypertension with endothelin receptor antagonist bosentan.
January 2003, Rheumatology (Oxford, England),
Masaki Shimizu, and Yoko Hashida, and Kazuyuki Ueno, and Tadafumi Yokoyama, and Yuko Nakayama, and Takekatsu Saito, and Kunio Ohta, and Kazuhiko Takehara, and Akihiro Yachie
[Pulmonary circulation in juvenile systemic hypertension].
January 1981, Ceskoslovenska fysiologie,
Masaki Shimizu, and Yoko Hashida, and Kazuyuki Ueno, and Tadafumi Yokoyama, and Yuko Nakayama, and Takekatsu Saito, and Kunio Ohta, and Kazuhiko Takehara, and Akihiro Yachie
Successful treatment of sarcoidosis-associated pulmonary hypertension with bosentan.
January 2008, Respiration; international review of thoracic diseases,
Masaki Shimizu, and Yoko Hashida, and Kazuyuki Ueno, and Tadafumi Yokoyama, and Yuko Nakayama, and Takekatsu Saito, and Kunio Ohta, and Kazuhiko Takehara, and Akihiro Yachie
Bosentan for the treatment of systemic sclerosis-associated pulmonary arterial hypertension, pulmonary fibrosis and digital ulcers.
August 2006, Expert opinion on pharmacotherapy,
Masaki Shimizu, and Yoko Hashida, and Kazuyuki Ueno, and Tadafumi Yokoyama, and Yuko Nakayama, and Takekatsu Saito, and Kunio Ohta, and Kazuhiko Takehara, and Akihiro Yachie
Bosentan ameliorated exercise-induced pulmonary arterial hypertension complicated with systemic sclerosis.
January 2010, Internal medicine (Tokyo, Japan),
Masaki Shimizu, and Yoko Hashida, and Kazuyuki Ueno, and Tadafumi Yokoyama, and Yuko Nakayama, and Takekatsu Saito, and Kunio Ohta, and Kazuhiko Takehara, and Akihiro Yachie
Successful treatment with bosentan for severe digital ischaemia in limited cutaneous systemic sclerosis.
August 2007, Annals of the rheumatic diseases,
Masaki Shimizu, and Yoko Hashida, and Kazuyuki Ueno, and Tadafumi Yokoyama, and Yuko Nakayama, and Takekatsu Saito, and Kunio Ohta, and Kazuhiko Takehara, and Akihiro Yachie
Successful Treatment of Pulmonary Arterial Hypertension in Systemic Sclerosis with Anticentriole Antibody.
January 2020, Case reports in rheumatology,
Masaki Shimizu, and Yoko Hashida, and Kazuyuki Ueno, and Tadafumi Yokoyama, and Yuko Nakayama, and Takekatsu Saito, and Kunio Ohta, and Kazuhiko Takehara, and Akihiro Yachie
Bosentan for severe pulmonary arterial hypertension related to systemic sclerosis with interstitial lung disease.
September 2006, European journal of clinical investigation,
Masaki Shimizu, and Yoko Hashida, and Kazuyuki Ueno, and Tadafumi Yokoyama, and Yuko Nakayama, and Takekatsu Saito, and Kunio Ohta, and Kazuhiko Takehara, and Akihiro Yachie
Successful treatment of persistent pulmonary hypertension of the newborn with bosentan.
October 2009, Acta paediatrica (Oslo, Norway : 1992),
Copied contents to your clipboard!